Stay updated on SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial

Sign up to get notified when there's something new on the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning to the term “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), and directs visitors to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-24T17:31:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T17:08:08.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T18:04:28.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    New revision entry v3.7.0 has been added to the study record history, and the previous revision v3.6.6 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-09-19T19:18:14.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the record history and the previous entry v3.6.5 was removed.
    Difference
    0.1%
    Check dated 2026-08-29T18:53:02.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The record history now reflects a new site version (v3.6.5) replacing the previous version (v3.6.4), indicating an internal update to the platform rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-08T10:27:05.000Z thumbnail image

Stay in the know with updates to SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page.